Other languages Valeo Pharma Inc.

Equities

VPH

CA91915B1085

Market Closed - Toronto S.E. Other stock markets 15:59:59 2024-06-28 EDT			5-day change	1st Jan Change
0.105 ^CAD	-8.70%		-4.55%	-41.67%

06-18	Valeo Pharma Names Chief Development Officer; Up Nearly 22%	MT
06-18	Valeo Pharma Inc. Appoints Al Moghaddam as Chief Development Officer and Consequently Steps Down from its Board of Directors	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Valeo Pharma Names Chief Development Officer; Up Nearly 22%	06-18
Valeo Pharma Inc. Appoints Al Moghaddam as Chief Development Officer and Consequently Steps Down from its Board of Directors	06-18
Valeo Pharma Fiscal Q2 Loss Widens 21% as Expenses Increase; Revenue Up 4%	06-14
Valeo Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	06-13
Valeo Pharma Announces Restructuring of Commercial Field Operations to Support Path to Profitability	06-13
Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	03-22
Valeo Pharma Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-14
Valeo Pharma Inc. Announces Board Changes	02-13
Valeo Pharma Amends Agreement with Novartis Pharmaceuticals Canada for (Pr)XIIDRA in Canada	02-02
Valeo Pharma's Q4'23 Net Loss Holds Steady YOY	01-30
Valeo Pharma Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	01-29
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer	12-04
Valeo Pharma Announces Organizational Changes and Cost Reduction Initiatives; Shares Jumped Near 30% Friday	11-20
Valeo Pharma Inc. Announces Appointment of Mr. Richard Lajoie to Board of Directors	11-07
Valeo Pharma's Fiscal Q3 Loss Widens, Revenue Grows; Up 3.5%	23-09-14
Valeo Pharma's Fiscal Q3 Loss Widens, Revenue Grows	23-09-14
Valeo Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-13
Valeo Pharma Inc. Announces Board Appointments	23-06-22
Valeo Pharma's Fiscal Q2 Loss Widens; Revenue Grows	23-06-14
Valeo Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Valeo Pharma Inc.

Equities

VPH

CA91915B1085

Other languages

Filters